Literature DB >> 24956269

Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population.

Katarzyna Komosinska-Vassev1, Dorota Blat2, Paweł Olczyk3, Anna Szeremeta2, Agnieszka Jura-Półtorak2, Katarzyna Winsz-Szczotka2, Katarzyna Klimek4, Krystyna Olczyk2.   

Abstract

OBJECTIVES: The influence of age and gender factor on the urinary excretion of total glycosaminoglycans (uGAGs) and their particular types: chondroitin/dermatan sulfates (CS/DSs), heparan sulfates (HSs) and hyaluronan (HA) was analyzed in healthy pediatric and adolescent population. DESIGN AND METHODS: Urine samples were collected from 95 healthy children. Sulfated GAGs excreted in the urine were quantitated using standardized dye-binding method, while the concentrations of HA were determined by immunoassay.
RESULTS: Age-dependent decline in total uGAG excretion (r=-0.686; p<0.001), resulting from a decrease in particular GAG fractions i.e. CS/DS (r=-0.757; p<0.001), HS (r=-0.401; p<0.05) and HA (r=-0.638; p<0.001), was found in healthy subjects. The observed differences were not gender specific with the exception of HS, in which excretion declines with age in males (r=-0.501; p<0.05) and does not change in females. Changes in the distribution pattern of uGAG were also found. CS/DS were the predominant uGAG's fraction, representing from 55% to 76% of the total GAGs. Children up to 3 years excreted more GAGs than older subjects and with a higher proportion of CS/DS and less content of HS. Moreover, the relative contribution of HA was increased twofold in adolescents, aged 15-18, as compared to younger subjects. A negative correlation existed between uGAG excretion and body height, except for HS, for which this relationship was found only in males.
CONCLUSIONS: Changes in urinary distribution pattern of particular GAG types during physiological human growth and development were found. Evaluation of urinary GAG screening procedures during pathological conditions should be based on the GAG/creatinine ratios with age and gender taken into account.
Copyright © 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chondroitin/dermatan sulfates; Extracellular matrix remodeling; Healthy children; Heparan sulfates; Hyaluronan; Urinary glycosaminoglycans

Mesh:

Substances:

Year:  2014        PMID: 24956269     DOI: 10.1016/j.clinbiochem.2014.06.012

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysaccharidosis I.

Authors:  Moin U Vera; Steven Q Le; Alla Victoroff; Merry B Passage; Jillian R Brown; Brett E Crawford; Lynda E Polgreen; Agnes H Chen; Patricia I Dickson
Journal:  Mol Genet Metab       Date:  2019-09-11       Impact factor: 4.797

2.  Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine.

Authors:  G V Coppa; O Gabrielli; L Zampini; F Maccari; V Mantovani; T Galeazzi; L Santoro; L Padella; R L Marchesiello; F Galeotti; N Volpi
Journal:  Metab Brain Dis       Date:  2015-05-29       Impact factor: 3.584

3.  Glycosylation and Aging.

Authors:  Ana Cindrić; Jasminka Krištić; Marina Martinić Kavur; Marija Pezer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

4.  Degradation of endothelial glycocalyx in Tanzanian children with falciparum malaria.

Authors:  Margaret A Bush; Salvatore M Florence; Tsin W Yeo; Ayam R Kalingonji; Youwei Chen; Donald L Granger; Matthew P Rubach; Nicholas M Anstey; Esther D Mwaikambo; Joe Brice Weinberg
Journal:  FASEB J       Date:  2021-09       Impact factor: 5.834

5.  Urinary sulfated glycosaminoglycan insufficiency and chondroitin sulfate supplement in urolithiasis.

Authors:  Thasinas Dissayabutra; Nuttiya Kalpongnukul; Kanokporn Chindaphan; Monpicha Srisa-Art; Wattanachai Ungjaroenwathana; Maroot Kaewwongse; Kroonpong Iampenkhae; Piyaratana Tosukhowong
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

6.  Nephrotoxic Effects of Paraoxon in Three Rat Models of Acute Intoxication.

Authors:  Vladislav E Sobolev; Margarita O Sokolova; Richard O Jenkins; Nikolay V Goncharov
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.